Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

Overview | Financials
Company Name Rocket Pharmaceuticals, Inc.
Symbol RCKT
Currency USD
Price 7.28
Market Cap 776,266,400
Dividend Yield 0%
52-week-range 4.55 - 26.98
Industry Biotechnology
Sector Healthcare
CEO Dr. Gaurav D. Shah M.D.
Website https://rocketpharma.com

An error occurred while fetching data.

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or

Related Stocks

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

2.5 USD

Evolus, Inc. logo

Evolus, Inc.

EOLS

11.57 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

2.33 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

0.741 USD

SIGA Technologies, Inc. logo

SIGA Technologies, Inc.

SIGA

5.76 USD

uniQure N.V. logo

uniQure N.V.

QURE

13.86 USD

Merus N.V. logo

Merus N.V.

MRUS

45.05 USD

Financials

Numbers are in millions USD

Numbers are in millions USD